ASTRO releases statement on RO Model delay in House Medicare provider relief bill

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Society for Radiation Oncology issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson in response to the introduction of the Supporting Health Care Providers During the COVID-19 Pandemic Act in the U.S. House of Representatives. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Readers of The Cancer Letter and listeners of The Cancer Letter Podcast are familiar with the impact of President Donald Trump’s first nine months in office on the field of oncology. Now, the threats posed to oncology are being brought to the attention of a general audience—Jonathan Mahler, staff writer for The New York Times Magazine, wrote an in-depth article about how the Trump administration’s actions have brought chaos, uncertainty, and damage to the oncology research community.
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login